Sayanam Rajeswari Ranga Anantha, Nachiappan Kanagathara, Khan Javed Masood, Ahmad Anis, Vijayakumar Natesan
Department of Biochemistry, School of Allied Health Sciences, VMKVMCH Campus, Vinayaka Mission's Research Foundation (DU), Salem, Tamil Nadu 636308 India.
Sri Lakshmi Narayana Institute of Medical Sciences, Pondicherry, 605502 India.
3 Biotech. 2023 Aug;13(8):284. doi: 10.1007/s13205-023-03703-y. Epub 2023 Jul 27.
This research was designed to evaluate the pharmaceutical potentials of various proportions of nanoemulsions, Nanoemulsion A and Nanoemulsion B (CHE-NE-A & CHE-NE-B) prepared from the hydroalcoholic extract of through in vitro approach, and their physicochemical properties were characterized using standard scientific analytical techniques. The physicochemical and morphological properties of CHE-NE-A and CHE-NE-B were characterized by FTIR, SEM, TEM, zeta potential, and scattering light intensity analyses. The results revealed that the size, shape, and exterior conditions of nano-droplets of the CHE-NE-A nanoemulsion were suitable as a drug carrier. The reports obtained from in vitro drug releasing potential analysis support this as well. CHE-NE-A nanoemulsion constantly removes the drug from the dialysis bag than CHE-NE-B. Moreover, the CHE-NE-A showed considerable dose-dependent antioxidant activity on DPPH, ABTS, and FRAP free radicals. CHE-NE-A and CHE-NE-B were tested for their antibacterial activity with various bacterial strains. The results demonstrated that the CHE-NE-A nanoemulsion showed remarkable antibacterial activity (zone of inhibition) against test bacterial pathogens than CHE-NE-B. The antibacterial activity of CHE-NE-A at a concentration of 200 µg mLwas in the following order, > > > > . Furthermore, CHE-NE-A has the lowest MIC values against these test bacterial pathogens than CHE-NE-B. Moreover, the CHE-NE-A also demonstrated good antifungal activity against the test fungal pathogens such as and than CHE-NE-B. These results strongly suggest that the CHE-NE-A nanoemulsion possesses considerable pharmaceutical potential. Interestingly, the physicochemical properties also rope that the CHE-NE-A nanoemulsion may be considered a drug carrier and useful for drug formulation.
本研究旨在通过体外方法评估由水醇提取物制备的不同比例纳米乳剂(纳米乳剂A和纳米乳剂B,即CHE-NE-A和CHE-NE-B)的药学潜力,并使用标准科学分析技术对其理化性质进行表征。通过傅里叶变换红外光谱(FTIR)、扫描电子显微镜(SEM)、透射电子显微镜(TEM)、zeta电位和散射光强度分析对CHE-NE-A和CHE-NE-B的理化和形态性质进行了表征。结果表明,CHE-NE-A纳米乳剂的纳米液滴大小、形状和外部条件适合作为药物载体。体外药物释放潜力分析得到的报告也支持这一点。CHE-NE-A纳米乳剂比CHE-NE-B能持续从透析袋中释放药物。此外,CHE-NE-A对二苯基苦味酰基自由基(DPPH)、2,2'-联氮-双-3-乙基苯并噻唑啉-6-磺酸自由基(ABTS)和铁还原抗氧化能力(FRAP)自由基显示出相当大的剂量依赖性抗氧化活性。对CHE-NE-A和CHE-NE-B进行了针对各种细菌菌株的抗菌活性测试。结果表明,CHE-NE-A纳米乳剂对受试细菌病原体显示出比CHE-NE-B更显著的抗菌活性(抑菌圈)。CHE-NE-A在浓度为200μg/mL时的抗菌活性顺序为……此外,CHE-NE-A对这些受试细菌病原体的最低抑菌浓度(MIC)值比CHE-NE-B低。此外,CHE-NE-A对受试真菌病原体如……也显示出比CHE-NE-B更好的抗真菌活性。这些结果强烈表明,CHE-NE-A纳米乳剂具有相当大的药学潜力。有趣的是,理化性质也表明CHE-NE-A纳米乳剂可被视为药物载体,对药物制剂有用。